These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16569203)

  • 1. 99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.
    Lazarowski A; Dupont J; Fernández J; Garay G; Florín A; Solimano J; Riveros D; Cacchione R
    Lymphat Res Biol; 2006; 4(1):23-8. PubMed ID: 16569203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of chemotherapy response in untreated malignant lymphomas using technetium-99m methoxyisobutylisonitrile scan: comparison with P-glycoprotein expression and other prognostic factors. A preliminary peport.
    Liang JA; Shiau YC; Yang SN; Lin FJ; Kao A; Lee CC
    Jpn J Clin Oncol; 2002 Apr; 32(4):140-5. PubMed ID: 12072424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
    Song HC; Lee JJ; Bom HS; Chung IJ; Kim HJ; Park YK; Kim EE
    Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the uptake and clearance of Tc-99m MIBI, Tl-201 and Ga-67 in drug-resistant lymphoma cell lines.
    Tsai SC; Shiau YC; Wang JJ; Ho YJ; Kao CH
    Cancer Lett; 2001 Oct; 171(2):147-52. PubMed ID: 11520598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
    Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of Tc-99m-MIBI scintigraphy in non-Hodgkin's lymphoma.
    Ohta M; Isobe K; Kuyama J; Uchida Y; Nakano K; Goto S; Uno T; Yasuda S; Shigematsu N; Kawata T; Kitahara H; Ito H
    Oncol Rep; 2001; 8(4):841-5. PubMed ID: 11410795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas.
    Kunishio K; Morisaki K; Matsumoto Y; Nagao S; Nishiyama Y
    Neurol Med Chir (Tokyo); 2003 Dec; 43(12):573-80; discussion 581. PubMed ID: 14723263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
    Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-MIBI uptake in small cell lung cancer.
    Bom HS; Kim YC; Song HC; Min JJ; Kim JY; Park KO
    J Nucl Med; 1998 Jan; 39(1):91-4. PubMed ID: 9443743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression.
    Liang JA; Shiau YC; Yang SN; Lin FJ; Lin CC; Kao A; Lee CC
    Oncol Rep; 2002; 9(2):307-12. PubMed ID: 11836597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging.
    Shih WJ; Rastogi A; Stipp V; Magoun S; Coupal J
    Clin Nucl Med; 1998 Aug; 23(8):505-8. PubMed ID: 9712381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
    Maurea S; Acampa W; Varrella P; De Rosa V; Fimiani P; Abate G; Salvatore M
    Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
    Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
    Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer].
    Shi D; Huang G; Miao J; Lin X
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):824-7. PubMed ID: 12126530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.
    Spyridonidis TJ; Matsouka P; Symeonidis A; Savvopoulos C; Vassilakos PJ; Apostolopoulos DJ
    Clin Nucl Med; 2013 Nov; 38(11):847-54. PubMed ID: 24089060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chemotherapy response using technetium-99M-sestamibi scintigraphy in untreated adult malignant lymphomas and comparison with other prognosis factors: a preliminary report.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
    Int J Cancer; 2001 Jul; 95(4):228-31. PubMed ID: 11400115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi.
    Kapucu LO; Akyüz C; Vural G; Oguz A; Atasever T; Büyükpamukçu M; Unlü M
    J Nucl Med; 1997 Feb; 38(2):243-7. PubMed ID: 9025746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.